Novel composition containing a conjugate of peg and interferon-alpha-2beta and providing reduced pain during administration

Proposed is a novel composition containing peginterferon alpha and adjuvants, more particularly disodium edetate dihydrate in a concentration of not more than 0.9 mg/ml, and providing reduced pain during administration.